GRACE :: Global Resource for Advancing Cancer Education
  • Recent GRACE News & Posts

    • This Is Not a Request for Donations... [GRACE :: News/Info]
      GRACE helps patients and their families figure things out during incredibly challenging times.   We know what you are going through, as much as any other person not living in your shoes can.  We are with you. So it makes us a little squeamish to ask you for a don
    • PFS vs. pfs: Why Progression-Free Survival Remains Controversial in Lung Cancer [GRACE :: Lung Cancer]
      Last year, an article came out in the Journal of Clinical Oncology that noted a gradual shift away from the "hard endpoint" of overall survival (OS) for lung cancer trials toward progression-free survival (PFS), a "softer endpoint" that is much more subject to inte
    • Questions & Answers with Drs. Pal, Luke and Wolchok about Immunotherapy for Cancer [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #31: "You know the world is changing when you have to change the rules..." Following presentations on endpoints and biomarkers in cancer immunotherapy, the doctors take questions from the audience. [powerpress]
    • The Immunotherapy Cola Wars [GRACE :: Lung Cancer]
      It's been a big week for immunotherapy for lung cancer. Right on the heels of a press release that the PD-1 inhibitor Opdivo (nivolumab) significantly improved survival for patients with advanced non-squamous NSCLC, my friend Dr. Garon from UCLA presented results a
    • Immunotherapy Opdivo (Nivolumab) Non-Squamous NSCLC Trial Stopped, Reported as Positive [GRACE :: Lung Cancer]
      In January, 2015, the CheckMate 017 trial of the immune checkpoint inhibitor Opdivo (nivolumab) versus the standard chemo agent Taxotere (docetaxel) as second line therapy for patients with advanced squamous NSCLC was reported in a press release to be positive for
    • Redefining Success and Failure in Cancer Immunotherapy Trials [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #30: Immunotherapy for cancer has rewritten the rules for what we consider a successful response to treatment. Some tumors grow before they regress. Dr. Jedd Wolchok discusses why a new measurement criteria was developed. [powerpress]
    • The Future of Cancer Immunotherapy: Combination Treatments [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #29: In part 2 of 2, Dr. Jason Luke discusses treating cancer with immunotherapy and another drug, such chemotherapy or targeted therapies, as well as what we know about biomarkers that predict if an immunotherapeutic will work. [powerpre
    • The Right Time for Cancer Immunotherapy: Before or After Surgery? [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #28: Doctors are still weighing the pros and cons of giving a cancer patient immunotherapy before or after resection surgery. In part 1 of 2 videos, Dr. Jason Luke details those risks and benefits. [powerpress]
    • Who Benefits from Immunotherapy? [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #27: Immunotherapies work well in some, but not in others. Who benefits, and why? Dr. Sumanta (Monty) Pal explains what doctors are learning. [powerpress]
    • Lung Cancer Immunotherapy Q&A [GRACE :: Lung Cancer]
      Immunotherapy Forum Video #26: Drs. Jared Weiss and Matthew Hellmann answer questions from the audience following their presentations on immunotherapy for lung cancer. Moderated by Dr. Jack West. [powerpress]
    • Benjamin Levy, MD, Hails 2015 as the Year of Lung Cancer Clinical Trials [GRACE :: Lung Cancer]
      Thoracic oncologist Dr. Ben Levy highlights what he believes was the biggest news for lung cancer patients in 2014 as well as his take on exciting clinical trials taking place in lung cancer in 2015. Download a transcript of the video [powerpress]  
    • Immunotherapy for Lung Cancer: Currently Enrolling Clinical Trials of Combination Therapies [GRACE :: Lung Cancer]
      Immunotherapy Forum Video #25: In Part 2 of 2 videos, Dr. Matthew Hellmann discusses currently enrolling clinical trials for lung cancer patients that study combination therapies (meaning an immunotherapy drug plus another drug is given). [powerpress]

Ask Us, Q&A

Volunteers Needed
We're Exhibiting At ASCO


Immunotherapy Patient Forum 2014 Videos


GRACE Website Rebuild

Acquired Resistance Forum Videos


ALK+ Lung Cancer Patient Forum Videos

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
   (Free Newsletter)

Recent GRACE Forum Topics

Recent GRACE Forum Replies

Other Resources

Biomedical Learning Institute